Differences in the Korea Acute Myocardial Infarction Registry Compared with Western Registries.
- Author:
Doo Sun SIM
1
;
Myung Ho JEONG
Author Information
- Publication Type:Review
- Keywords: Myocardial infarction; Risk factors; Hydroxymethylglutaryl-CoA reductase inhibitors; Percutaneous coronary intervention
- MeSH: Asian Continental Ancestry Group; Aspirin; Cholesterol; Drug-Eluting Stents; Dyslipidemias; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Korea*; Lipoproteins; Mortality; Myocardial Infarction*; Percutaneous Coronary Intervention; Prevalence; Registries*; Risk Factors; Secondary Prevention; Shock, Cardiogenic; Stents; Thrombosis; Triglycerides
- From:Korean Circulation Journal 2017;47(6):811-822
- CountryRepublic of Korea
- Language:English
- Abstract: The Korea Acute Myocardial Infarction Registry (KAMIR) is the first nationwide registry that reflects current therapeutic approaches and acute myocardial infarction (AMI) management in Korea. The results of the KAMIR demonstrated different risk factors and responses to medical and interventional treatments. The results indicated that the incidence of ST-elevation myocardial infarction (STEMI) was relatively high, and that the prevalence of dyslipidemia was relatively low with higher triglyceride and lower high-density lipoprotein cholesterol levels. Percutaneous coronary intervention (PCI) rates were high for both STEMI and non-ST-elevation myocardial infarction (NSTEMI) with higher use of drug-eluting stents (DESs). DES were effective and safe without increased risk of stent thrombosis in Korean AMI patients. Triple antiplatelet therapy, consisting of aspirin, clopidogrel, and cilostazol, was effective in preventing adverse clinical outcomes after PCI. Statin therapy was effective in Korean AMI patients, including those with very low levels of low-density lipoprotein cholesterol and those with cardiogenic shock. The KAMIR score had a greater predictive value than Thrombolysis in Myocardial Infarction (TIMI) and Global Registry of Acute Coronary Events (GRACE) scores for long-term mortality in AMI patients. Based on these results, the KAMIR will be instrumental for establishing new therapeutic strategies and effective methods for secondary prevention of AMI and guidelines for Asian patients.
